1. |
Jursen H. Antibiotic treatment of infectious endocarditis. Tidsskr Nor Laegeforen, 200l, 121 (28):3300-3305.
|
2. |
Dido LL, Child IS. Infection endocarditis in congenital heart disease. Cardiol Clin, 1996, 14 (3):383-392.
|
3. |
符竣, 陶涼, 陳緒發, 等. 感染性心內膜炎外科治療時機. 中國胸心血管外科臨床雜志, 2003, 10 (2):147-148.
|
4. |
Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis:utilization of speci?c echocardiographic ?ndings. Am J Med , 1994, 96 (3):200-209.
|
5. |
Bayer AS, Ward JI, Ginzton LE, et al. Evaluation of new clinical criteria for the diagnosis of infective endocarditis. Am J Med, 1994, 96 (3):211-219.
|
6. |
張爾永, 石應康, 程述森. 原發性感染性心內膜炎瓣膜損害的外科治療. 中國胸心血管外科臨床雜志, 1999, 6 (2):83.
|
7. |
Pierce D, Calkins BC, Thornton K. Infectious endocarditis:diagnosisand treatment. Am Fam Physician, 2012, 85 (10):981-986.
|
8. |
Houpikian P, Raoult D. Blood culture-negative endocarditis in a refer-ence center:etiologic diagnosis of 348 cases. Medicine, 2005, 84 (3):162-173.
|
9. |
Piper C, Horstkotte D. Endocarditis:current diagnosis and therapy. Med Klin (Munich), 2008, 103 (4):217-227.
|
10. |
Brouqui P, Raoult D. Endocarditis due to rare and fastidious bacteria.Clin Microbiol Rev, 2001, 14 (1):177-207.
|
11. |
Christoph K, Naber, Erbel R, et al. Infective endocarditis with negative blood cultures. Int J Antimicrob Agents, 2007, 30 (Suppl 1):S32-36.
|
12. |
Gauduchon V, Chalabreysse L, Etienne J, et al. Molecular diagnosisof infective endocarditis by PCR amplification and direct sequencing of DNA from valve tissue. J Clin Microbiol, 2003, 41 (2):763-766.
|
13. |
Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis, 2000, 30 (4):633-638.
|
14. |
Jassal DS, Aminbakhsh A, Fang T, et al. Diagnostic value of harmonic transthoracic echocardiography in native valve infective endocarditis:comparison with transesophageal echocardiography. Cardiovasc Ultrasound, 2007, 5 (5):20.
|
15. |
Christoph KH. German guidelines for the diagnosis and management of infective endocarditis. Int J Antimicrob Agents, 2007, (29):643–657.
|
16. |
Chen FJ. A clinical analysis of 36 cases of infective endocarditis. Practical Clinical Med, 2007, 25 (1):14-118.
|
17. |
Naber CK, Paul-Ehrlich-Gesellschaft für Chemotherapie, Deutschen Gesellschaft für Kardiologie, Herz- und Kreislaufforschung, et al. S2 guideline for diagnosis and therapy of infectious endocarditis. Z Kardiol, 2004, 93 (12):1005-1021.
|
18. |
王波, 閻德民, 肖德棉, 等. 感染性心內膜炎的診斷與治療. 中國胸心血管外科臨床雜志, 2010, 17 (1):70-72.
|
19. |
Paul-Ehrlich-Gesellschaft für Chemotherapie (PEG;Paul-Ehrlich-Society for Chemotherapy), Deutsche Gesellschaft für Kardiologie, Herz-und Kreislaufforschung (DGK), German Society for Cardiology, Heart, and Circulatory Research). German guidelines for the diagnosis and management of infective endocarditis.Int J Antimicrob Agents, 2007, 29 (6):643-657.
|
20. |
吳泉明, 胡辛蘭. 26例感染性心內膜炎瓣膜贅生物病原菌分布及耐藥性分析. 實驗與檢驗醫學, 2011, 29 (6):589-592, 604.
|
21. |
Martínez-Sellés M, Muñoz P, Estevez A, et al. Long-term outcome of infective endocarditis in non-intravenous drug users. Mayo Clin Proc, 2008, 83 (11):1213-1217.
|
22. |
Vikram HR, Buenconsejo J, Hasbun R, et al. Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis:a propensity analysis. JAMA, 2003, 290 (24):3207-3214.
|
23. |
Tran CT, Kjeldsen K. Endocarditis at a tertiary hospital:reduced acute mortality but poor long term prognosis. Scand J Infect Dis, 2006, 38 (8):664-670.
|
24. |
Cabell CH, Abrutyn E, Fowler VG Jr, et al. Use of surgery in patients with native valve infective endocarditis:results from the International Collaboration on Endocarditis Merged Database. Am Heart J, 2005, 150 (5):1092-1098.
|
25. |
Tornos P, Iung B, Permanyer-Miralda G, et al. Infective endocarditis in Europe:lessons from the Euro heart survey. Heart, 2005, 91 (5):571-575.
|